Your Health Today
New Drug Could Double Survival Time for Pancreatic Cancer Patients
A new drug may be the most significant breakthrough in pancreatic cancer treatment in years, according to a study released this week. Researchers say daraxonrasib doubled how long patients survived compared to a second round of chemotherapy, offering real hope for a disease that often kills within months.
The study followed 500 patients who had already gone through chemotherapy. Those who received a second chemo drug lived, on average, about 6.7 months. Patients who got daraxonrasib instead lived more than 13 months.
The drug works by targeting a gene called K-RAS, which acts like an on/off switch controlling how cells grow. In more than 90% of pancreatic cancers, that gene mutates and gets stuck in the "on" position, causing cancer cells to grow out of control. Daraxonrasib blocks that mutation, stopping it from doing more damage.
The drug's side effects are considered less toxic than chemotherapy, though they are not mild. Some patients develop mouth sores and a severe blistering rash. Former Nebraska Senator Ben Sasse, who participated in the clinical trial, described the experience on a podcast as "nuclear," saying it felt like "burning, bubbling."
The FDA has fast-tracked daraxonrasib for approval. Researchers are also studying whether it can fight other cancers. The same K-RAS mutation it targets is a key driver in lung, colon, ovarian, and endometrial cancers. Though patients and doctors are celebrating the results, researchers are careful to note that daraxonrasib is not a cure.
By: NBC Palm Springs
June 1, 2026
Latest Instagram Posts
Social Time with Thalia & Jerry
What do you think is really going on here? Drop your thoughts below 👇 #therogginreport #coachella #coachellavalley #localnews #nbcpalmsprings
During the 2025-2026 school year, PEN America reported there were nearly 12,000 book bans in public schools nationwide, the largest number of book bans in a single year since the group started tracking numbers in 2021.
Delta Airlines overhauled its frequent flyer program in 2024. CNN’s Randi Kaye asks Delta CEO Ed Bastian if the airline has made it more difficult for flyers to earn status and if any further changes to the loyalty program are on the horizon.
Social Time with Thalia & Jerry. Favorite Festival?
‘The Hayden’ is back @babysmarche !! John Hayden himself took a trip to the Indian Wells staple for lunch and to chat with @chefjustinsnyder on how it became the most popular item on the menu! #TheHayden
🛑A bike ride ended in tragedy Monday night in Palm Springs. A bicyclist died after being struck by a car around 8:30 PM on E. Palm Canyon Dr. The driver stayed at the scene and police say there’s no indication of foul play or impairment. ❓Saw the crash or have video from the area? Call Palm Springs police at (760) 327–1441.
Social Time: Jerry sings the end! 🎶🎵
CALIFORNIA IS AGING FAST... BUT WHERE WILL THE WORKFORCE LIVE? #therogginreport #coachellavalley #localnews #agingpopulation #nbcpalmsprings
119 jobs on the line and DRD’s General Manager won’t answer questions … Drop a comment 👇: Would you vote YES or NO on giving a district more money if they refuse to answer transparency questions? #therogginreport #drd #coachellavalley #localnews #nbcpalmsprings